
H&Q Life Sciences Investors Declares Stock Dividend Hambrecht & Quist Capital Management LLC
Boston, Nov 11, 2005 -- On November 11, 2005, H&Q Life Sciences Investors declared a stock dividend of $1.09 per share. The record date for the stock dividend is November 21, 2005 and the payable date is December 30, 2005. The Fund will trade ex-dividend on November 17, 2005. This stock distribution will automatically be paid in newly issued shares of the Fund unless otherwise instructed by the shareholder. The shares will be valued at the lower of the net asset value or market price on the pricing date, December 20, 2005. Fractional shares will generally be settled in cash, except for registered shareholders with book entry accounts at the transfer agent who will have whole and fractional shares added to their account.
Shareholders may request to be paid in cash instead of shares by responding to the bank, brokerage or nominee who holds the shares if the shares are in "street name" or by filling out an election card received from Computershare Investor Services shortly after the record date if the shares are in registered form. The bank, brokerage or nominee who holds the shares must advise the Depository Trust Company ("DTC") as to their full and fractional share requirements by December 19, 2005. Written notification for the election of cash instead of stock by registered shareholders must be received by Computershare Investor Services prior to December 19, 2005.
Since the Fund's inception on May 8, 1992, the Fund's net asset value per share has ranged from a high of $44.80 to a low of $9.98 (unadjusted for capital gains of $16.82). The market price per share has ranged from a high of $41.063 to a low of $8.125. The stock price to net asset value premium has been as high as 13.7% and the discount as wide as 29.9%. On November 10, 2005, the closing stock price was $16.71 and the net asset value per share was $17.62, representing a discount of 5.16%.
H&Q Life Sciences Investors (HQL) is a closed-end fund that invests in public and private companies in the life sciences industries. Hambrecht & Quist Capital Management LLC, based in Boston, serves as Investment Adviser to the Fund. Shares of the Fund can be purchased on the New York Stock Exchange through any securities broker.
View more information on Hambrecht & Quist Capital Management or other Closed-End Funds
|
©1999-2008 Closed-End Fund Association, Inc. All Rights Reserved
 | | Powered by a SySys® data & content management system. Click here to learn more. |
|
|